Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)
用户slK1Kxicm8Dw
1个月前
43
10
已完结
1. 系统已在2025-12-12 11:13:49对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1182/blood-2023-174420
其他信息:
出版社: American Society of Hematology
作者: Wei Yang; Sujun Gao; Xiaojing Yan; Rong Guo; Lijie Han; Fei Li; Yafei Wang; Junmin Li; Chunkang Chang; Haiping Yang; Ronghua Hu; Hongyan Tong; Xingli Zhao; Qiubai Li; Jingdong Zhang; Xin Du; Sanfang Tu; Cheng Zhang; Congmeng Lin; Xin Du; Zhenling Li; Ligen Liu; Zhenyu Li; Zheng Dong; Yixuan Yang; Qiying Lu; Wenzhi Tian; Zhijian Xiao
全文下载地址: https://ashpublications.org/blood/article-pdf/142/Supplement%201/320/2199037/blood-4924-main.pdf
